These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19588332)

  • 1. Interventions in the management of serum lipids for preventing stroke recurrence.
    Manktelow BN; Potter JF
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD002091. PubMed ID: 19588332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions in the management of serum lipids for preventing stroke recurrence.
    Manktelow B; Gillies C; Potter JF
    Cochrane Database Syst Rev; 2002; (3):CD002091. PubMed ID: 12137644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack.
    Zonneveld TP; Richard E; Vergouwen MD; Nederkoorn PJ; de Haan R; Roos YB; Kruyt ND
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD007858. PubMed ID: 30024023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin: its clinical role in cerebrovascular prevention.
    Gaspardone A; Arca M
    Drugs; 2007; 67 Suppl 1():55-62. PubMed ID: 17910521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2014 Jan; (1):CD010693. PubMed ID: 24399670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins for acute ischemic stroke.
    Squizzato A; Romualdi E; Dentali F; Ageno W
    Cochrane Database Syst Rev; 2011 Aug; (8):CD007551. PubMed ID: 21833959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers for preventing stroke recurrence.
    De Lima LG; Saconato H; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007890. PubMed ID: 25317988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack.
    Sandercock PA; Gibson LM; Liu M
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD000248. PubMed ID: 19370555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers for preventing stroke recurrence.
    De Lima LG; Soares BG; Saconato H; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2013 May; (5):CD007890. PubMed ID: 23728669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for improving modifiable risk factor control in the secondary prevention of stroke.
    Bridgwood B; Lager KE; Mistri AK; Khunti K; Wilson AD; Modi P
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009103. PubMed ID: 29734470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrates for primary prevention of cardiovascular disease events.
    Jakob T; Nordmann AJ; Schandelmaier S; Ferreira-González I; Briel M
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009753. PubMed ID: 27849333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patches of different types for carotid patch angioplasty.
    Orrapin S; Benyakorn T; Howard DP; Siribumrungwong B; Rerkasem K
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD000071. PubMed ID: 33598915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.